Company / Shares Outstanding
Kura Oncology, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
78.2M
FY2025
5-year range
66.4M / 78.2M
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
#121 of 212
Health Care
What the data says
At 78229000.00, Kura Oncology, Inc.'s shares outstanding ranks #92 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 18701000.00 in FY2016 to 78229000.00 in FY2025.
Based on SEC 10-K filings.
78229000.00 in FY2025 with a 5-year CAGR of +8.1%.
Increased from 73229000.00 to 78229000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +5.3%
- 5-Year CAGR
- +8.1%
- 10-Year CAGR
- -
Sector benchmark
#92 of 212 in Health CareTop 43% of 212This company 78.2M Sector average 306.7M
▼
-74.5% below sector average
Key checks
Key Insights
- Kura Oncology, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 5.2% year-over-year.
- Ranks #121 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 78.2M | +5.2% |
| FY2024 | 74.3M | +1.5% |
| FY2023 | 73.2M | +9.3% |
| FY2022 | 67.0M | +1.0% |
| FY2021 | 66.4M | +25.0% |
| FY2020 | 53.1M | +26.5% |
| FY2019 | 41.9M | +19.2% |
| FY2018 | 35.2M | +51.4% |
| FY2017 | 23.2M | +24.3% |
| FY2016 | 18.7M | +88.3% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026